tapentadol aachen-pharma grt retard 25 mg retardtabletten
aachen-pharma grt gmbh (1011057) - tapentadolhydrochlorid - retardtablette - tapentadolhydrochlorid (32875) 29,12 milligramm
tapentadol aachen-pharma grt retard 50 mg retardtabletten
aachen-pharma grt gmbh (1011057) - tapentadolhydrochlorid - retardtablette - tapentadolhydrochlorid (32875) 58,24 milligramm
tapentadol aachen-pharma grt akutschmerz 50 mg filmtabletten
aachen-pharma grt gmbh (1011057) - tapentadolhydrochlorid - filmtablette - tapentadolhydrochlorid (32875) 58,24 milligramm
tapentadol aachen-pharma grt retard 250 mg retardtabletten
aachen-pharma grt gmbh (1011057) - tapentadolhydrochlorid - retardtablette - tapentadolhydrochlorid (32875) 291,2 milligramm
tapentadol aachen-pharma grt retard 200 mg retardtabletten
aachen-pharma grt gmbh (1011057) - tapentadolhydrochlorid - retardtablette - tapentadolhydrochlorid (32875) 232,96 milligramm
tapentadol aachen-pharma grt retard 150 mg retardtabletten
aachen-pharma grt gmbh (1011057) - tapentadolhydrochlorid - retardtablette - tapentadolhydrochlorid (32875) 174,72 milligramm
tapentadol aachen-pharma grt retard 100 mg retardtabletten
aachen-pharma grt gmbh (1011057) - tapentadolhydrochlorid - retardtablette - tapentadolhydrochlorid (32875) 116,48 milligramm
tapentadol aachen-pharma grt akutschmerz 100 mg filmtabletten
aachen-pharma grt gmbh (1011057) - tapentadolhydrochlorid - filmtablette - tapentadolhydrochlorid (32875) 116,48 milligramm
tapentadol aachen-pharma grt akutschmerz 75 mg filmtabletten
aachen-pharma grt gmbh (1011057) - tapentadolhydrochlorid - filmtablette - tapentadolhydrochlorid (32875) 87,36 milligramm
sapropterin dipharma
dipharma arzneimittel gmbh - sapropterin dihydrochloride - phenylketonurien - anderen verdauungstrakt und stoffwechsel-produkte, - sapropterin dipharma is indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with phenylketonuria (pku) who have been shown to be responsive to such treatment. sapropterin dipharma is also indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with tetrahydrobiopterin (bh4) deficiency who have been shown to be responsive to such treatment.